Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Cibus Inc

CBUS ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: BUY

Last Close

$1.58

▲ +1.28%

Market Cap $120.76M · Vol 11.11K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$120.76M

Micro Cap

Div Yield

N/A

EPS Growth

+61.51%

YoY

RSI (14)

27.91

Momentum

Beta

1.60

vs Market

52W High

$4.17

62.59% below

52W Low

$1.10

41.82% above

Volume

11.11K

Avg 40.55K

P/B

4.33

Price-to-book

ROE

N/A

Return on equity

Free Float

73.90%

Public shares

Shariah Compliance8 STANDARDS

✗ Cibus Inc (CBUS) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CBUS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.39%

-16.40%

+13.67%

-55.24%

YTD

-9.20%

+23.44%

-89.40%

-99.25%

Financials & Valuation

TTM · Annual

Total Revenue	$3.64M
Net Income	$-132,201,000.00
Revenue Growth (YoY)	+6.54%
Gross Margin	100.00%
Operating Margin	-1,853.92%
Net Profit Margin	-3,632.89%
ROE	N/A
ROA · ROIC	-40.35% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	21.88
P/B	4.33
P/FCF	N/A
EPS Growth	+61.51%
Outstanding Shares	76.43M

Technical Indicators

50-Day SMA	$1.75
200-Day SMA	$1.87
RSI (14)	27.91
Beta	1.60
52-Week High	$4.17
52-Week Low	$1.10

Volume Today	11.11K
Avg Daily Volume (30D)	40.55K
Relative Volume	0.27x
Volatility (10D)	26.15
Volatility (30D)	50.16
Free Float	73.90%

Analyst Consensus

BUY

Current Price $1.58

Mean Target $14.00

52W Low$1.10 52W High$4.17

Current

Target

$1.10 $4.17

Current Analyst target

+786.08% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00H1CJSR3

ISINUS17166A1016

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 11, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc +1.63% DHR Danaher Corp +0.53% ISRG Intuitive Surgical Inc -0.55% BSX Boston Scientific Corp -2.94% EW Edwards Lifesciences Corp -1.15%

Company Profile

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.